Bli medlem
Bli medlem

Du är här


DSM N.V. : DSM finalizes acquisition of Aland (China)

Royal DSM, the global Life
Sciences and Materials Sciences company, today announces it has finalized the
acquisition of Aland,
a Hong Kong-based company producing vitamin C in mainland China.
The acquisition was announced on 11 July 2014.

Aland was founded in 1990 and is one of the leading Vitamin C manufacturers in
China. It has a production facility in Jingjiang, Jiangsu Province in China.
In 2014 the company realized net sales of about USD 110 million in vitamin C
with around 1,800 employees. The transaction excludes Aland's consumer health

DSM - Bright Science. Brighter Living.(TM)

Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and
Materials Sciences DSM is driving economic prosperity, environmental progress
and social advances to create sustainable value for all stakeholders
simultaneously. DSM delivers innovative solutions that nourish, protect and
improve performance in global markets such as food and dietary supplements,
personal care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM
and its associated companies deliver annual net sales of about €10 billion
with approximately 25,000 employees. The company is listed on Euronext
Amsterdam. More information can be found

Or find us on:

For more information:

| DSM Corporate Communications DSM Investor Relations |
|Herman Betten |
|tel. +31 (0) 45 5782017 Dave Huizing |
|e-mail tel. +31 (0) 45 5782864 |
| e-mail |
Press release-pdf


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.